Bora CDMO Bora CDMO

X

Find Radio Compass News for Fludarabine

PharmaCompass
Related ProductsRelated Products
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

USP

JP

0

Other Listed Suppliers

SERVICES

0

https://www.fiercebiotech.com/biotech/nkarta-touts-cell-therapy-effectiveness-specific-lymphodepletion-regiment-durability

Max Bayer FIERCE BIOTECH
27 Jun 2023

https://www.biospace.com/article/crispr-therapeutics-announces-promising-data-for-its-car-t-cancer-therapy/?s=71

Mark Terry BIOSPACE
13 Oct 2021

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-1-2021-1630499458.pdf

FDA
01 Sep 2021

https://www.prnewswire.com/news-releases/cbmg-holdings-novel-anti-cd20-car-t-cell-therapy-shows-promising-safety-and-efficacy-in-relapsedrefractory-b-cell-non-hodgkin-lymphoma-patients-following-relapse-to-an-anti-cd19-car-t-therapy-301310049.html

PRNEWSWIRE
10 Jun 2021

https://www.prnewswire.com/news-releases/cbmg-holdings-novel-cd19cd20-bi-specific-car-t-cell-product-shows-early-promising-clinical-efficacy-and-favorable-safety-profile-in-relapsed-or-refractory-b-cell-non-hodgkin-lymphoma-301310047.html

PRNEWSWIRE
10 Jun 2021

https://www.businesswire.com/news/home/20191207005033/en/Imbruvica%C2%AE%E2%96%BC-ibrutinib-Combination-Therapy-Data-Studies-Long-Term/?feedref=JjAwJuNHiystnCoBq_hl-WBlLQO14j4QZPTyX5CYOnwC4VjN53jumZRlnzhBoBxGrCOi9QzgjCezTS3Nw_X6kJUrpSBm-Hav1w-UkdSlG3ltkRSnqzf6ourQGu_UA28CzZCGORvG0LE20YOvo49uqw==

BUSINESSWIRE
09 Dec 2019

https://www.biospace.com/article/unum-plunges-after-fda-places-another-clinical-hold-on-company-asset/

BIOSPACE
04 Jul 2019

https://www.pharmacompass.com/pdf/news/jiangsu-yew-pharmaceutical-co-ltd-fails-edqm-inspection-1537438043.pdf

EDQM
15 Sep 2018

http://www.fiercebiotech.com/biotech/juno-notches-positive-data-for-next-line-car-t-jcar017

Ben Adams FIERCE BIOTECH
05 Jun 2017

http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203738

FDA
02 Mar 2017

https://globenewswire.com/news-release/2016/12/12/896995/0/en/European-Commission-Grants-Marketing-Authorization-for-Arzerra-ofatumumab-in-combination-with-Fludarabine-and-Cyclophosphamide-in-Relapsed-CLL.html

GLOBENEWSWIRE
12 Dec 2016

http://www.in-pharmatechnologist.com/Regulatory-Safety/Juno-deaths-CAR-T-experts-suspect-therapy-at-fault-not-the-field

Dani Bancroft IN PHARMATECHNOLOGIST
01 Dec 2016

http://www.fiercepharma.com/partnering/does-trump-presidency-mean-changes-for-pharma-marketing-and-advertising

BS Bulik FIERCE PHARMA
29 Nov 2016

http://www.fiercebiotech.com/biotech/adaptimmune-stock-slides-after-poor-efficacy-forces-it-to-add-fludarabine-to-regimen

Nick Paul Taylor FIERCE BIOTECH
12 Oct 2016

https://www.pharmacompass.com/pdf/news/zhejiang-hisun-pharmaceutical-co-ltd-yantou-campus-fails-edqm-inspection-1483966941.pdf

EDQM
19 Sep 2016

http://www.biospectrumasia.com/biospectrum/news/221144/taigen-initiates-clinical-trial-leukemia-drug-china

BIOSPECTRUM BUREAU BIOSPECTRUM ASIA
04 May 2015
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY